Detalhe da pesquisa
1.
Sequencing of novel agents in relapsed/refractory B-cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia.
Cancer
; 127(7): 1039-1048, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33259056
2.
Taking a "BiTE out of ALL": blinatumomab approval for MRD-positive ALL.
Blood
; 133(16): 1715-1719, 2019 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30796026
3.
Mechanisms of Immune Tolerance in Leukemia and Lymphoma.
Trends Immunol
; 38(7): 513-525, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28511816
4.
Health Care Sharing Ministries: What Are the Risks to Consumers and Insurance Markets?
Issue Brief (Commonw Fund)
; 2018: 1-12, 2018 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30091863
5.
How I treat acute lymphoblastic leukemia in older adolescents and young adults.
Blood
; 125(24): 3702-10, 2015 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-25805810
6.
Efforts to Support Consumer Enrollment Decisions Using Total Cost Estimators: Lessons from the Affordable Care Act's Marketplaces.
Issue Brief (Commonw Fund)
; 3: 1-12, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28182371
7.
Factors Affecting Health Insurance Enrollment Through the State Marketplaces: Observations on the ACA's Third Open Enrollment Period.
Issue Brief (Commonw Fund)
; 19: 1-12, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27459742
8.
To Transplant or Not? Weighing the Risks of Blinatumomab Prior to Hematopoietic Stem Cell Transplant in Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 26(9): e209-e210, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32445796
9.
Phosphoinositide 3-kinase inhibitors in lymphoma.
Curr Opin Oncol
; 26(5): 469-75, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25024054
10.
Characteristics of Health Care Settings Where Adolescents and Young Adults Receive Care for ALL.
JCO Oncol Pract
; 20(4): 491-502, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252911
11.
Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemia.
JCI Insight
; 9(8)2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38646934
12.
Acute lymphoblastic leukemia in young adults: which treatment?
Hematology Am Soc Hematol Educ Program
; 2023(1): 587-592, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066918
13.
Asparaginase toxicity in Hispanic adult and pediatric patients with acute lymphoblastic leukemia: current understanding.
Expert Opin Drug Metab Toxicol
; 19(6): 357-366, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410014
14.
Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation.
Blood Adv
; 7(6): 963-970, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973200
15.
Innovative Approaches to the Management of Acute Lymphoblastic Leukemia Across the Age Spectrum.
Am Soc Clin Oncol Educ Book
; 42: 1-11, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35503981
16.
Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia.
Blood Adv
; 6(5): 1608-1618, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34610109
17.
Multi-institutional study evaluating clinical outcome with allogeneic hematopoietic stem cell transplantation after blinatumomab in patients with B-cell acute lymphoblastic leukemia: real-world data.
Bone Marrow Transplant
; 56(8): 1998-2004, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33824440
18.
Role of blinatumomab, inotuzumab, and CAR T-cells: Which to choose and how to sequence for patients with relapsed disease.
Semin Hematol
; 57(3): 157-163, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33256906
19.
Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Leuk Lymphoma
; 61(3): 614-622, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31680584
20.
Real-World Outcomes of Adult B-Cell Acute Lymphocytic Leukemia Patients Treated With Inotuzumab Ozogamicin.
Clin Lymphoma Myeloma Leuk
; 20(8): 556-560.e2, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32291234